Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an investigation Wednesday into the “outrageously high prices” of Novo ...
That's because the U.S. Food and Drug ... drugs when prescribed for obesity," KFF said in a news release. How the FDA's change affects Medicare spending will depend in part on how many Part D ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage ...
Even if they're not acquired, these small companies are developing promising obesity ... add up to a nice investment opportunity. First, corporate buyouts are back in style. Second, weight-loss ...
"It's not all about weight loss," he said, adding that semaglutide ... in people with obesity or who are overweight. The growing list of potential uses for obesity drugs has been driving up ...
“It’s not all about weight loss,” he said, adding that semaglutide ... and often linked with obesity. The growing list of potential uses for obesity drugs has been driving up expectations ...
Revlimid and Avastin — and anti-diabetic and obesity drugs — Victoza, Januvia and Trulicity, among others — are nearing patent expiration. Some other high-selling drugs in the list include Stelara, a ...